Pharmacyte Biotech Inc. (PMCB)
NASDAQ · Healthcare
Pharmacyte Biotech Inc. Operating Income 2011–2025
Pharmacyte Biotech Inc. annual/quarterly operating income history and growth rate from 2012 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Pharmacyte Biotech Inc. operating income for the quarter ending January 31, 2026 was -2.1 M, a 120.58% increase year-over-year.
- Pharmacyte Biotech Inc. operating income for the twelve months ending January 31, 2026 was -5.3 M, a 6.20% decrease year-over-year.
- Pharmacyte Biotech Inc. annual operating income for 2025 was -4.4 M, a 48.62% decrease from 2024.
- Pharmacyte Biotech Inc. annual operating income for 2024 was -8.5 M, a 31.98% increase from 2023.
- Pharmacyte Biotech Inc. annual operating income for 2023 was -6.5 M, a 46.98% increase from 2022.
- Pharmacyte Biotech Inc. annual operating income for 2022 was -4.4 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Pharmacyte Biotech Inc. Operating Income — FAQ
Pharmacyte Biotech Inc. (PMCB) operating income over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is Pharmacyte Biotech Inc.'s operating income?
Pharmacyte Biotech Inc. (PMCB) reported operating income of -$4M for fiscal 2025.
Where can I see PMCB's operating income history?
The chart and table above show Pharmacyte Biotech Inc.'s operating income by year and by quarter, including the growth rate.